|
Mr. Grey previously served as a director for Epimmune and since January 1 2005 he has served as President and Chief Executive Officer of Structural GenomiX Inc. a privately held biotechnology company where he previously served as President from June 2003 to January 1 2005 and as Chief Business Officer from April 1 2001 until June 2003. In addition Mr. Grey has been a member of the board of directors of Structural GenomiX since September 2001. Between January 1999 and September 2001 he served as President and Chief Executive Officer of Trega Biosciences Inc. a biotechnology company. Prior to joining Trega Mr. Grey served as President of BioChem Therapeutics Inc. a division of BioChem Pharma Inc. a pharmaceutical company from November 1994 to August 1998. During 1994 Mr. Grey served as President and Chief Operating Officer of Ansan Inc. a biopharmaceutical company. From 1974 to 1993 Mr. Grey served in various roles with Glaxo Inc. and Glaxo Holdings plc a pharmaceutical company culminating in his position as Vice President Corporate Development. Mr. Grey serves on the board of directors of Achillion Pharmaceuticals Inc.
| 